2025年公募基金产品"中考"放榜，医药主题基金成为业绩排名大赢家。今年一季度期间，一度霸屏的人形机器 人赛道基金产品全部淡出十强，当前排名中期业绩前十的产品中有七只为医药主题基金，且这些医药主题基金 产品均大比例持有港股仓位，同时重仓单一行业的赛道化打法也主导基金业绩格局，前十的基金产品中仅有一 只基金产品在持仓上采取"均衡"策略。 排名今年全市场"中考"业绩十强的诺安价值精选基金经理唐晨认为，港股创新药仓位对基金产品至关重要，应 重点把握具备重磅炸弹潜力的大单品赛道，尤其是肿瘤、代谢性疾病、自身免疫病这三大赛道的创新药需求刚 性，因此也具有更大的投资机会。 人形机器人赛道基淡出 公募基金产品2025年上半年十强业绩今日出炉，以人形机器赛道为核心仓位的基金产品未能进入业绩十强。 Wind数据显示，截至2025年6月30日收盘，汇添富香港优势精选基金今年上半年累计收益率为86%，位列全市 场公募基金"中考"业绩冠军、中信建投北交所精选基金、长城医药产业精选基金位列全市场前三，2025年上半 年的"中考"业绩分别达到82.45%、75.18%。此外，华夏北交所精选基金、中银港股通医药基金、永赢医药创 新基金、广 ...

转自：新华财经 新华财经香港6月30日电（记者李柏涛）27日，16家内地企业递表申请在港股主板上市，其中13家是第一次递表；30日，云知声、IFBH、泰德医药三家公 司在港交所挂牌上市，这是6月份第四次出现"三重奏"…… 实际上，2025年上半年，港股IPO市场强势复苏，新股发行节奏加快、募资规模回升，成为全球资本市场关注的焦点。 新股认购数据显示，5月在港上市的宁德时代，吸引来自欧洲、中东和美国等地的投资者参与，其IPO集资规模也刷新了港股近年纪录。 政策制度红利释放 港交所数据显示，今年上半年已完成42宗传统IPO项目，累计集资超过1050亿港元，规模也分别超过了2022年、2023年、2024年的全年融资规模。 业内人士认为，这一亮眼成绩的背后，是国际资金转向、政策制度红利释放、估值修复与流动性改善等多重动能的叠加共振，为港股市场注入了新的活力 与韧性。 国际资金投资转向 今年上半年，全球经济在复杂环境中缓慢修复，地缘冲突与科技浪潮并行，国际资金流动逻辑正从"避险主导"向"收益与风险再平衡"切换。 港股IPO市场走热并非偶然。德勤中国华南区主管合伙人欧振兴指出，香港作为国际金融中心，是全球资本配置中国资 ...

Group 1 - The core viewpoint of the article is that the Hong Kong Stock Exchange (HKEX) has regained its position as the world's leading IPO market, with a significant increase in fundraising activities in the first half of 2025 [2][14]. - According to Ernst & Young's report, HKEX's IPO fundraising accounted for 24% of the global total in the first half of 2025, surpassing both NASDAQ and NYSE [2]. - The number of IPOs and the amount raised in Hong Kong are expected to grow by 33% and 711% respectively compared to the same period last year [2]. Group 2 - As of June 20, 2025, HKEX had 31 IPO projects with a total fundraising of 884 billion HKD, exceeding the total amount raised in the previous year [2]. - The average fundraising amount for IPOs in Hong Kong in 2023 was only 6.77 million HKD, marking a ten-year low, with only one IPO exceeding 5 billion HKD [3]. - The IPO market in Hong Kong has seen a turnaround this year, with several notable IPOs contributing to the market's recovery [3][4]. Group 3 - Notable IPOs this year include the toy company Bluc, which set a record with a subscription amount of 877.5 billion HKD, and the beverage company Mixue, which raised 1.84 trillion HKD in subscriptions [4][8]. - The performance of newly listed companies like Mixue and InnoCare has significantly improved market sentiment, with Mixue's stock price rising by 153.6% from its issue price [8][9]. - The influx of southbound capital through the Stock Connect program has reached a record net inflow of 186 billion HKD in the first half of 2025, indicating strong investor interest [9][13]. Group 4 - The structure of the Hong Kong stock market is changing, with a shift towards sectors such as healthcare, technology, and consumer goods, which have shown strong performance [11][12]. - The Hang Seng Index has seen significant gains, reaching its highest levels since 2021, driven by strong performances from various sectors [11]. - The article highlights the potential for continued growth in the Hong Kong IPO market, with expectations for over 50 new economy companies to list in the second half of 2025, potentially raising over 160 billion HKD [13][14].

今年上半年，南向资金累计净流入港股市场近7300亿港元。随着南向资金持续流入，港股流动性显著改 善，港股与A股的流动性差距迎来趋势性收窄，而作为南向资金核心增配方向之一的港股银行板块，成为 AH溢价率大幅下降的最大推手。 包括中欧瑞博、兴证策略等多家机构表示，港股潜在回报率更高，好公司的港股折价将会很快填平，以银行股 为代表的高股息资产中仍有优秀且便宜的公司，从目前10年期国债利率在2%以内来看，这些高股息资产仍有 相当吸引力。 港股流动性直追A股 "我们此前部分产品投港股的上限是30%，但现在上限已经全部打开，可以全部买港股。"康曼德资本创始人丁 楹在近日论坛上表示，未来产品很多收益可能将来自港股。 Wind数据显示，南下资金年内已累计净买入近7300亿港元，为历史同期最高。相较2024年全年也仅相差约800 亿港元。南向资金持续流入对港股市场流动性和估值体系产生深远影响。 在流动性层面上，港股成交金额大幅攀升，换手率与A股流动性正在追平。截至6月27日，本月南向资金合计 买卖成交总额达到2.28万亿港元，已高于5月全月成交额1.80万亿港元。 兴证策略研究报告指出，今年以来，港股与A股流动性差距显著收窄， ...

智通财经6月30日电，今年以来，港股市场IPO呈现井喷式格局。截至6月30日，已有43家顺利上市，而 去年同期仅有30家。值得一提的是，今年上半年港股IPO募集资金达1067.14亿港元，已超去年全年的 876.77亿港元，同时也创下3年新高。若按交易所排名，港交所IPO募资规模位居全球榜首。其中今年5 月、6月的募资总额为572.85亿港元、278.68亿港元。 (21财经) 港股上半年千亿募资领跑全球 总额已超去年全年 ...

Group 1 - A total of 8 Hong Kong companies launched their IPOs on June 30, including companies from various sectors such as robotics, semiconductors, and biomedicine [1] - In the first half of 2025, Hong Kong welcomed 43 new IPOs, a 43.3% increase from 30 in the same period of 2024, with total funds raised amounting to approximately HKD 1,067.1 billion [2][4] - The top three IPOs by fundraising in the first half of 2025 were Ningde Times, Heng Rui Pharmaceutical, and Hai Tian Wei Ye, raising HKD 410.1 billion, HKD 113.7 billion, and HKD 101.3 billion respectively, accounting for 58.6% of the total IPO fundraising [7][8] Group 2 - The healthcare and consumer discretionary sectors had the highest number of new listings in 2025, with 10 and 8 companies respectively, while the industrial sector led in fundraising [9] - Among the 43 new IPOs, 27 companies saw their stock prices rise on the first day of trading, resulting in a first-day drop rate of 30.2% [9][10] - The most significant first-day price increases were recorded by Ying En Biotechnology-B and Yao Jie An Kang-B, with gains of 116.7% and 78.7% respectively [10][12] Group 3 - The IPO subscription rates were notably high, with several companies experiencing over 1,000 times subscription, including Bluco, which had a subscription rate of 6,000 times [13][14] - A total of 35 out of 43 companies triggered the allocation mechanism, indicating a higher success rate for companies that utilized this strategy [16] - As of June 30, 2025, there were 134 companies that received approval for overseas IPOs, with over 160 companies currently in the queue for Hong Kong IPOs [18]

今年以来，港股表现强势，互联网、新消费、创新药轮番上涨，成为中国资产中一道亮眼的风景线。 在富国基金港股通红利精选基金经理、海外权益部投资总监宁君看来，"好公司是港股最大的优势"。今年以 来，她管理多只基金凭借对新消费、互联网的前瞻布局脱颖而出，以富国蓝筹精选为例，2025年一季报显示， 该基金同时重仓了泡泡玛特、浪潮数字企业、网易云音乐等。截至2025年6月24日，近一年收益率超45%，在 同类基金中排名前列。 而对于估值，她相较灵活："我们都希望拿到市场性价比最高的公司，但估值没有固定标准。在有一些市场环 境下，结合基本面分析，容易下结论股票是明确低估或者高估；而在另一些情况下则需要随行就市，在有的市 场或者行业，10倍PE可能很贵，换一种情况，15倍也可能便宜，关键看性价比。" 她以某潮玩龙头举例说道："它的核心IP均为独家授权，这种独占性构筑了护城河。虽然市场曾质疑其IP生命 周期，但实际运营中，越是爆火的IP反而越可能延续——粉丝基数形成天然壁垒，这种壁垒一旦形成，成长空 间和盈利韧性会远超预期，然后快速消化估值。" 在采访中，宁君多次提及潮玩龙头这一"现象级案例"，深度研究后，宁君说道："类比国外 ...

Core Viewpoint - The Hong Kong stock market is experiencing a surge in IPO activity, with multiple companies set to list in the coming days, indicating a robust market environment for new listings [1][3][18]. Group 1: Upcoming IPOs - On June 30, six companies announced their IPOs, with plans to list between June 30 and July 4, 2025 [1][3]. - The companies planning to list include Lens Technology, Fortior, Xunzhong Communication, Jizhi Jia, Dazhong Oral, and Shougang Longze, with Lens Technology and Fortior being A-share listed companies [1][3]. - Three companies, including Taide Pharmaceutical, Yunzhisheng, and IFBH, successfully listed on June 30, 2025, with Taide Pharmaceutical's share price set at 30.6 HKD [1][4]. Group 2: Financial Performance of Listed Companies - Yunzhisheng reported revenues of approximately 601 million RMB, 727 million RMB, and 939 million RMB for 2022, 2023, and 2024, respectively, with net losses of 375 million RMB, 376 million RMB, and 454 million RMB [4][6]. - Taide Pharmaceutical raised approximately 514 million HKD, with a net amount of about 429 million HKD after expenses, and secured two cornerstone investors contributing a total of 10 million USD [8]. - IFBH raised around 1.158 billion HKD, with a net amount of approximately 1.074 billion HKD, and is recognized as the second-largest coconut water beverage company globally [8]. Group 3: Market Trends and Future Outlook - The Hong Kong stock exchange has seen over 40 new listings in the first half of 2025, a significant increase compared to the same period in 2024, with total fundraising exceeding 100 billion HKD [17]. - The market is expected to remain active, with more companies preparing for IPOs, including those that have already submitted applications [17][18]. - The trend indicates a growing interest from A-share listed companies to enter the Hong Kong market, with over 70 companies submitting applications in June 2025 alone [17].

Market Performance - The Hang Seng Index closed down by 0.87% while the Hang Seng Tech Index fell by 0.72% [1] - The Hong Kong Stock Connect ETF (159318) increased by 0.38% and the Hong Kong Tech ETF (159751) rose by 0.19% [1] Sector Performance - The new consumption sector led the gains, with Lao Pu Gold surging by 14% [1] - The banking sector experienced declines, with Qingdao Bank (002948) dropping over 3% [1]

以下文章来源于养基场王场长 ，作者王场长 养基场王场长 . 牢记基金投资中的第一性原理——通过基金赚钱。 关注我们，陪伴我们，一起成长，一起赚钱。 风险提示：本文所提到的观点仅代表个人的意见，所涉及标的不作推荐，据此买卖，风险自负。 作者： 养基场王场长 来源：雪球 唐朝的开国名将 ， 商朝的陈塘关总兵 ， 佛教的毗沙门天王 ， 道教的阐教三代弟子 ， 天庭的托塔天王 。 这些跨越了千年历史与人神佛三界的title ， 都归于一个人 —— 李靖 ， 哪吒他爹 。 而在投资中 ， 如果要选出一个能有如此多title的存在 ， 那我想一定是港股的科技主题 。 目前市场上比较 纯粹的 ， 跟踪港股科技主题的指数就有十个 ， 跟踪的基金就高达125只 。 | 指数名称 | 发布日期 | 指数类型 | 产品跟踪数量 | 近1年收益率 | 发布机构 | | --- | --- | --- | --- | --- | --- | | 恒生科技 | 2020-07-27 | 股票指数 | 54 (ETF: 10) | 32.57% | 恒生指数有限公司 | | 恒生互联网科技业 | 2015-08-17 | 股票指数 | 1 ...